Certified by Founder Lodge
Samsara BioCapital
United States - Palo Alto, California INVESTOR
1 Disclosed Funding Rounds $90,000,000
13 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
N/A
| Company | Date | Round | Raised |
|---|---|---|---|
 SpyGlass Pharma, Inc. | July, 11 ,2023 | Series C | $90,000,000 |
 Septerna | July, 18 ,2023 | Series B | $150,000,000 |
 Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
 OrsoBio | November, 08 ,2023 | Series A | $60,000,000 |
 EyeBio | November, 15 ,2023 | Series A | $65,000,000 |
 Seismic Therapeutic | December, 05 ,2023 | Series B | $121,000,000 |
 FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
 Alumis | March, 07 ,2024 | Series C | $259,000,000 |
 Candid Therapeutics | September, 10 ,2024 | Unknown | $370,000,000 |
 Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
 Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |
 A2 Biotherapeutics, Inc. | January, 10 ,2025 | Series C | $80,000,000 |
 Normunity | January, 14 ,2025 | Series B | $75,000,000 |
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sympera AI | $10,000,000 | (Apr 2, 2025)
InfiniLink | $10,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
